Evidence map›Paper›PMID 39017894›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Flow Cytometric Identification of Human IgE

Karrnan Pathmanandavel, Stuart G Tangye, Cindy S Ma

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karrnan PathmanandavelGarvan Institute of Medical Research, Darlinghurst, NSW, Australia. K.Pathmanandavel@garvan.org.au.
Stuart G TangyeGarvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Cindy S MaGarvan Institute of Medical Research, Darlinghurst, NSW, Australia. c.ma@garvan.org.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of flow cytometry for immunophenotyping is contingent on the ability to accurately assign biological relevance to the detected signal. This process has historically been challenging when defining IgE expressing B cells or IgE expressing antibody-secreting cells due to widespread expression of receptors for IgE on various leukocyte subsets, including human B cells. Here we describe our implementation of intracellular staining for human IgE following a blocking step to negate the challenge of surface-bound IgE. We also describe our experience with a human B cell culture system that can be used to robustly validate this approach before application to primary human samples. Orthogonal confirmatory techniques remain essential; these are not described in detail, but several possible strategies are suggested.

Indexed as

Flow CytometryImmunoglobulin EImmunophenotypingB-LymphocytesB-Lymphocyte SubsetsCell LineageHumansReceptors, IgEImmunoglobulin EReceptors, IgEAllergyFlow cytometryHuman B cellsImmunoglobulin E (IgE)ImmunophenotypingInborn errors of immunity (IEI)

Identifiers

PMID39017894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.